Utility of patient-reported outcomes in assessing treatment response in rheumatoid arthritis:: Humira® efficacy response optimization (HERO) trial.

被引：0
|
作者：
Wolfe, F.
Michaud, K.
Pincus, T.
Kent, J. D.
Pangan, A. L.
机构：
[1] Natl Data Bank Rheumat Dis, Wichita, KS USA
[2] Vanderbilt Univ, Nashville, TN USA
[3] Abbott, Abbott Pk, IL USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S424 / S425
页数：2
相关论文
共 50 条
  • [1] Safety of Humira in patients with active rheumatoid arthritis who participated in the Humira® Efficacy Response Optimization (HERO) study
    Pangan, A. L.
    Kent, J. D.
    Krzywicki, D.
    Nelson, L. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 483 - 484
  • [2] Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
    Michael, Doumen
    Diederik, De Cock
    Sofia, Pazmino
    Delphine, Bertrand
    Johan, Joly
    Rene, Westhovens
    Patrick, Verschueren
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [3] Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
    Michaël Doumen
    Diederik De Cock
    Sofia Pazmino
    Delphine Bertrand
    Johan Joly
    René Westhovens
    Patrick Verschueren
    Arthritis Research & Therapy, 23
  • [4] Clinical response by day 1 with adalimumab in patients with active rheumatoid arthritis: Humira efficacy response optimization (HERO) study.
    Wolfe, F.
    Michaud, K.
    Pincus, T.
    Kent, J. D.
    Pangan, A. L.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S424 - S424
  • [5] Treatment Response and Several Patient-reported Outcomes Are Early Determinants of Future Self-efficacy in Patients with Rheumatoid Arthritis
    Doumen, Michael
    De Cock, Diederik
    Pazmino, A.
    Bertrand, Delphine
    Westhovens, Rene
    Verschueren, Patrick
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1628 - 1631
  • [6] Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
    Michaël Doumen
    Diederik De Cock
    Sofia Pazmino
    Delphine Bertrand
    Johan Joly
    René Westhovens
    Patrick Verschueren
    Arthritis Research & Therapy, 23
  • [7] Patient-Reported Outcomes in Rheumatoid Arthritis
    van Tuyl, Lilian H. D.
    Michaud, Kaleb
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (02) : 219 - +
  • [8] Patient-reported outcomes in rheumatoid arthritis
    Her, Minyoung
    Kavanaugh, Arthur
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (03) : 327 - 334
  • [9] Sarilumab: patient-reported outcomes in rheumatoid arthritis
    Crotti, Chiara
    Biggioggero, Martina
    Becciolini, Andrea
    Favalli, Ennio Giulio
    PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 275 - 284
  • [10] An effective measure of treatment efficacy: The VAS stiffness severity scale: Results from the Humira Efficacy Response Optimization (HERO) trial
    Wolfe, F
    Michaud, K
    Pincus, T
    Pangan, AL
    Kent, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S343 - S344
12345